rs6902416

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_006073.4(TRDN):​c.601C>G​(p.Leu201Val) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.859 in 1,475,352 control chromosomes in the GnomAD database, including 546,877 homozygotes. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★). Another nucleotide change resulting in the same amino acid substitution has been previously reported as Likely benign in ClinVar. Another variant affecting the same amino acid position, but resulting in a different missense (i.e. L201P) has been classified as Uncertain significance.

Frequency

Genomes: 𝑓 0.85 ( 54736 hom., cov: 32)
Exomes 𝑓: 0.86 ( 492141 hom. )

Consequence

TRDN
NM_006073.4 missense

Scores

18

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:10

Conservation

PhyloP100: -1.20

Publications

26 publications found
Variant links:
Genes affected
TRDN (HGNC:12261): (triadin) This gene encodes an integral membrane protein found in skeletal and cardiac muscle. The encoded protein plays a role in skeletal muscle excitation-contraction coupling as part of the calcium release complex and is required for normal skeletal muscle strength. This protein indirectly links triads and microtubules in skeletal muscle. Mutations in this gene are associated with cardiac arrythmia syndrome and some variants in this gene may be associated with sudden cardiac death. [provided by RefSeq, May 2022]
TRDN Gene-Disease associations (from GenCC):
  • catecholaminergic polymorphic ventricular tachycardia
    Inheritance: AD, AR Classification: DEFINITIVE, SUPPORTIVE Submitted by: Orphanet, ClinGen
  • catecholaminergic polymorphic ventricular tachycardia 5
    Inheritance: AR Classification: DEFINITIVE, STRONG Submitted by: Labcorp Genetics (formerly Invitae), G2P, Genomics England PanelApp
  • familial long QT syndrome
    Inheritance: AR Classification: STRONG Submitted by: G2P
  • long QT syndrome
    Inheritance: AR Classification: STRONG Submitted by: ClinGen

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=8.0956585E-7).
BP6
Variant 6-123512312-G-C is Benign according to our data. Variant chr6-123512312-G-C is described in ClinVar as Benign. ClinVar VariationId is 227123.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.862 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
TRDNNM_006073.4 linkc.601C>G p.Leu201Val missense_variant Exon 7 of 41 ENST00000334268.9 NP_006064.2 Q13061-1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
TRDNENST00000334268.9 linkc.601C>G p.Leu201Val missense_variant Exon 7 of 41 1 NM_006073.4 ENSP00000333984.5 Q13061-1

Frequencies

GnomAD3 genomes
AF:
0.848
AC:
128902
AN:
152002
Hom.:
54705
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.801
Gnomad AMI
AF:
0.887
Gnomad AMR
AF:
0.874
Gnomad ASJ
AF:
0.818
Gnomad EAS
AF:
0.883
Gnomad SAS
AF:
0.843
Gnomad FIN
AF:
0.875
Gnomad MID
AF:
0.807
Gnomad NFE
AF:
0.866
Gnomad OTH
AF:
0.852
GnomAD2 exomes
AF:
0.845
AC:
164187
AN:
194390
AF XY:
0.841
show subpopulations
Gnomad AFR exome
AF:
0.776
Gnomad AMR exome
AF:
0.874
Gnomad ASJ exome
AF:
0.808
Gnomad EAS exome
AF:
0.877
Gnomad FIN exome
AF:
0.860
Gnomad NFE exome
AF:
0.847
Gnomad OTH exome
AF:
0.861
GnomAD4 exome
AF:
0.861
AC:
1139075
AN:
1323232
Hom.:
492141
Cov.:
25
AF XY:
0.859
AC XY:
565678
AN XY:
658342
show subpopulations
African (AFR)
AF:
0.788
AC:
23971
AN:
30416
American (AMR)
AF:
0.876
AC:
32676
AN:
37288
Ashkenazi Jewish (ASJ)
AF:
0.814
AC:
19639
AN:
24136
East Asian (EAS)
AF:
0.889
AC:
33582
AN:
37776
South Asian (SAS)
AF:
0.830
AC:
62592
AN:
75370
European-Finnish (FIN)
AF:
0.868
AC:
43483
AN:
50110
Middle Eastern (MID)
AF:
0.809
AC:
4343
AN:
5366
European-Non Finnish (NFE)
AF:
0.865
AC:
871951
AN:
1007794
Other (OTH)
AF:
0.852
AC:
46838
AN:
54976
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.415
Heterozygous variant carriers
0
6411
12821
19232
25642
32053
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
19152
38304
57456
76608
95760
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.848
AC:
128981
AN:
152120
Hom.:
54736
Cov.:
32
AF XY:
0.847
AC XY:
62973
AN XY:
74362
show subpopulations
African (AFR)
AF:
0.800
AC:
33204
AN:
41504
American (AMR)
AF:
0.874
AC:
13346
AN:
15268
Ashkenazi Jewish (ASJ)
AF:
0.818
AC:
2840
AN:
3470
East Asian (EAS)
AF:
0.884
AC:
4569
AN:
5170
South Asian (SAS)
AF:
0.842
AC:
4064
AN:
4826
European-Finnish (FIN)
AF:
0.875
AC:
9237
AN:
10560
Middle Eastern (MID)
AF:
0.789
AC:
232
AN:
294
European-Non Finnish (NFE)
AF:
0.866
AC:
58874
AN:
68002
Other (OTH)
AF:
0.854
AC:
1806
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.503
Heterozygous variant carriers
0
1013
2026
3038
4051
5064
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
892
1784
2676
3568
4460
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.854
Hom.:
17993
Bravo
AF:
0.844
TwinsUK
AF:
0.862
AC:
3196
ALSPAC
AF:
0.876
AC:
3375
ESP6500AA
AF:
0.799
AC:
2828
ESP6500EA
AF:
0.861
AC:
6904
ExAC
AF:
0.826
AC:
96620
Asia WGS
AF:
0.844
AC:
2928
AN:
3466

ClinVar

Significance: Benign
Submissions summary: Benign:10
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Benign:7
-
Clinical Genetics, Academic Medical Center
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

Nov 24, 2014
Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Leu201Val in exon 7 of TRDN: This variant is not expected to have clinical signi ficance because it has been identified in 20.1% (710/3538) of African American c hromosomes from a broad population by the NHLBI Exome Sequencing Project (http:/ /evs.gs.washington.edu/EVS; dbSNP rs6902416). -

Apr 09, 2025
Molecular Diagnostic Laboratory for Inherited Cardiovascular Disease, Montreal Heart Institute
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Sep 21, 2016
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. -

Jul 08, 2021
Women's Health and Genetics/Laboratory Corporation of America, LabCorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

-
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

-
Diagnostic Laboratory, Department of Genetics, University Medical Center Groningen
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

Catecholaminergic polymorphic ventricular tachycardia 1 Benign:1
Feb 04, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Cardiovascular phenotype Benign:1
Mar 09, 2015
Ambry Genetics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This alteration is classified as benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. -

Catecholaminergic polymorphic ventricular tachycardia 5 Benign:1
Sep 10, 2021
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.048
BayesDel_addAF
Benign
-0.58
T
BayesDel_noAF
Benign
-0.47
CADD
Benign
1.3
DANN
Benign
0.21
DEOGEN2
Benign
0.075
T;.;.
Eigen
Benign
-1.5
Eigen_PC
Benign
-1.5
FATHMM_MKL
Benign
0.0029
N
LIST_S2
Benign
0.049
T;T;T
MetaRNN
Benign
8.1e-7
T;T;T
MetaSVM
Benign
-1.0
T
MutationAssessor
Benign
-1.2
N;N;.
PhyloP100
-1.2
PrimateAI
Benign
0.38
T
PROVEAN
Benign
-0.12
N;.;N
REVEL
Benign
0.046
Sift
Benign
1.0
T;.;T
Sift4G
Benign
0.36
T;T;T
Polyphen
0.0
B;.;.
Vest4
0.014
ClinPred
0.000013
T
GERP RS
-3.4
Varity_R
0.035
gMVP
0.00083
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs6902416; hg19: chr6-123833457; COSMIC: COSV62125755; COSMIC: COSV62125755; API